Development Level

Tbio 15 | 11,445
Tdark 2 | 6,588
Tchem 1 | 1,598

IMPC Phenotype

preweaning lethality, incomple... 3 | 499
embryonic lethality prior to o... 2 | 239
embryonic lethality prior to t... 2 | 278
abnormal cecum morphology 1 | 7
abnormal coat-hair pigmentatio... 1 | 64
abnormal embryo size 1 | 220
abnormal embryo turning 1 | 31
abnormal seminal vesicle morph... 1 | 114
decreased bone mineral content 1 | 151
decreased bone mineral density 1 | 126
decreased circulating insulin ... 1 | 76
decreased fasted circulating g... 1 | 65
decreased lymphocyte cell numb... 1 | 83
decreased mean corpuscular vol... 1 | 79
decreased total body fat amoun... 1 | 207
enlarged cecum 1 | 5
enlarged heart 1 | 210
enlarged ovary 1 | 2
enlarged spleen 1 | 41
increased body length 1 | 32
increased circulating alkaline... 1 | 122
increased lean body mass 1 | 172
increased monocyte cell number 1 | 63
increased neutrophil cell numb... 1 | 46
iris synechia 1 | 3
preweaning lethality, complete... 1 | 979

Disease

Carcinoma 14 | 11,493
ovarian cancer 14 | 8,520
osteosarcoma 13 | 7,950
medulloblastoma, large-cell 9 | 6,241
glioblastoma 7 | 5,792
Kidney cancer 6 | 2,613
ependymoma 6 | 4,679
group 3 medulloblastoma 6 | 4,104
atypical teratoid / rhabdoid tumor 5 | 5,112
oligodendroglioma 5 | 2,850
Breast cancer 4 | 3,578
astrocytic glioma 4 | 2,597
invasive ductal carcinoma 4 | 2,951
psoriasis 4 | 6,694
tuberculosis 4 | 2,010
Alzheimer's disease 3 | 658
Muscle hypotonia 3 | 571
Pick disease 3 | 1,894
cystic fibrosis 3 | 1,696
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,955
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,291
juvenile dermatomyositis 3 | 1,187
lung cancer 3 | 4,740
pancreatic cancer 3 | 2,398
primitive neuroectodermal tumor 3 | 3,035
spina bifida 3 | 1,074
Acquired metabolic disease 2 | 336
Astrocytoma, Pilocytic 2 | 3,081
Autosomal dominant nonsyndromic deafness 9 2 | 5
Autosomal recessive predisposition 2 | 1,442
Cognitive delay 2 | 608
Death in early childhood 2 | 82
Death in infancy 2 | 82
Dull intelligence 2 | 645
Global developmental delay 2 | 608
Intellectual disability 2 | 1,016
Low intelligence 2 | 645
Mental Retardation 2 | 645
Mental and motor retardation 2 | 608
Mental deficiency 2 | 645
Poor school performance 2 | 645
Rheumatoid arthritis 2 | 1,191
active Crohn's disease 2 | 922
active ulcerative colitis 2 | 764
acute quadriplegic myopathy 2 | 1,158
adult high grade glioma 2 | 3,801
aldosterone-producing adenoma 2 | 665
diabetes mellitus 2 | 1,728
ductal carcinoma in situ 2 | 1,745
group 4 medulloblastoma 2 | 1,855
interstitial cystitis 2 | 2,312
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
lung adenocarcinoma 2 | 2,716
non primary Sjogren syndrome sicca 2 | 891
non-small cell lung cancer 2 | 2,890
posterior fossa group B ependymoma 2 | 416
primary pancreatic ductal adenocarcinoma 2 | 1,109
progressive supranuclear palsy 2 | 676
sonic hedgehog group medulloblastoma 2 | 467
subependymal giant cell astrocytoma 2 | 2,287
Adverse reaction to drug 1 | 61
Atrial Septal Defects 1 | 85
Big calvaria 1 | 147
Breast Neoplasms 1 | 445
Calcific tendinitis 1 | 8
Cerebellar hypoplasia and atrophy 1 | 41
Charcot-Marie-Tooth disease 1 | 62
Ciliopathy 1 | 71
Congenital Camptodactyly 1 | 40
Dental caries 1 | 164
Dental fluorosis 1 | 20
Denture stomatitis 1 | 11
Distal amyotrophy 1 | 51
Distal sensory impairment 1 | 52
Downward slant of palpebral fissure 1 | 158
Drug-Related Side Effects and Adverse Reactions 1 | 62
Ellis-Van Creveld syndrome 1 | 19
Epicondylitis 1 | 22
Griscelli syndrome 1 | 24
Hypsarrhythmia 1 | 25
Increased size of cranium 1 | 147
Increased size of skull 1 | 147
Leukemia, Acute Myeloid 1 | 17
Leukemia, Myelocytic, Acute 1 | 120
Low posterior hairline 1 | 52
Mammary Neoplasms 1 | 425
Periventricular nodular heterotopia 1 | 30
Prominent back of the head 1 | 21
Prominent occiput 1 | 21
Protrusion of tongue 1 | 11
Pseudobulbar palsy 1 | 11
Pulmonary Stenosis 1 | 45
Quadriparesis 1 | 8
Recurrent respiratory infections 1 | 141
Retinal Hemorrhage 1 | 6
Silver-Russell syndrome 1 | 39
Tetralogy of Fallot 1 | 63
X- linked recessive 1 | 110
facioscapulohumeral dystrophy 1 | 288
sarcoidosis 1 | 370

Tissue

Blood and immune system 18 | 16,909
Cardiovascular System 18 | 15,192
Digestive Tract 18 | 17,369
Endocrine System 18 | 18,159
Female tissues 18 | 17,400
Liver and Pancreas 18 | 16,750
Male tissues 18 | 17,142
Nervous System 18 | 16,725
Respiratory system 18 | 16,393
Skin and soft tissues 18 | 17,230
Urinary Tract 18 | 16,678

Target Family

Non-IDG 16 | 12,091
Enzyme 2 | 4,145

GO Process

Golgi to plasma membrane trans... 18 | 18
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Cysteine-rich hydrophobic domain-containing protein 2 CHIC2 Tbio Non-IDG -2.12710 132.1 97
Rab-3A-interacting protein RAB3IP Tbio Non-IDG -1.03500 11.6 89
Brefeldin A-inhibited guanine nucleotide-exchange protein 2 ARFGEF2 Tbio Non-IDG -1.15371 14.4 81
Metalloreductase STEAP2 STEAP2 Tbio Enzyme -1.78852 56.5 154
Ras-related protein Rab-10 RAB10 Tbio Enzyme -1.62208 41.1 164
Exocyst complex component 4 EXOC4 Tbio Non-IDG -1.61492 39.1 121
Coiled-coil domain-containing protein 93 CCDC93 Tdark Non-IDG -0.25890 1.05 156
UPF0505 protein C16orf62 VPS35L Tdark Non-IDG -0.00735 0.72 29
Exocyst complex component 5 EXOC5 Tbio Non-IDG -1.45220 28.7 83
Exocyst complex component 2 EXOC2 Tbio Non-IDG -1.73003 48.8 86